An elevated expression of AARS2 has been highlighted among most cancers, especially colorectal cancer (CRC) [49], hepatocellular carcinoma (HCC), and COAD, and it is closely associated with poor prognosis and survival in HCC and COAD patients [50,51]. The gene discussed is AARS2; the disease is hepatocellular carcinoma.